Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Depomed initiates dosing in phase III clinical trial of Gabapentin GR in postherpetic neuralgia

March 27, 2008

Corcept initiates phase III trial of Corlux for the psychotic features of psychotic depression

March 27, 2008

Novel analgesic agents reported in recent patent literature

March 27, 2008

Neuropharm commences phase II NPL-2009 trial in Fragile X syndrome

March 26, 2008

Anesiva initiates phase III Adlea trial for postsurgical pain

March 26, 2008

Recent patents report novel therapeutic agents for neurological disorders

March 26, 2008

ReNeuron updates strategy for ReN-001

March 25, 2008

Peptimmune completes phase I novel peptide copolymer trial in MS

March 25, 2008

Mapreg's MAP-4343 granted orphan status in Europe for spinal cord injury

March 20, 2008

Nerve growth factor mimetic peptide effective in rat neuropathic pain model

March 19, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 6, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...